Locations for Utah’s medical marijuana companies have been selected

Salt Lake City will be among the first locations to house Utah’s medical marijuana businesses.

This is along with other northern Utah sites including West Bountiful, Ogden, Logan, Park City, Provo, Linden, and Springville. Other locations include Box Elder County, Morgan County or Rich County. The southern sites are Cedar City and St. George, while the only site in eastern Utah is Vernal.

The department said that some locations may change due to several processes still underway, including site acquisitions, criminal background checks, and operational plan reviews. Some places may open in March, while others would open in July, the department said.

In order to find more on this subject, one potentially useful cannabis investing tool is the Hemp.im app. This app collects the latest marijuana news among cannabis sectors that investors operate in.

The competitive processes behind Utah’s medical marijuana locations

Department of Health officials said that the locations were evaluated and chosen through a competitive qualification process from more than 130 applications from 60 companies.

Criteria included experience with medical marijuana, regulatory compliance, connections with the local community, and a strategic plan with a high likelihood of success.

“It was a highly competitive process and some qualified applicants will be disappointed, but that’s the nature of such a process,” said Richard Oborn, Director of the Center for Medical Cannabis, which is part of the health agency.

Osborn said the selection of sites is an important milestone for the launch of Utah’s medical marijuana program. It allows companies to start checking their locations and hiring employees.

Cannabis and the law in Utah

Utah voters approved the initiative that legalizes physician-approved marijuana treatment for certain health conditions in November 2018.

State lawmakers replaced the measure with a law that they say establishes stricter controls over the production, distribution, and use of the drug in the following month.

__

(Featured image by 12019 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in TelemundoUtah, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.